General Information of the Protein
Protein ID
PT04545
Protein Name
Delta(24)-sterol reductase
Secondarily
Protein Name
24-dehydrocholesterol reductase
3-beta-hydroxysterol Delta-24-reductase
Diminuto/dwarf1 homolog
Seladin-1
Gene Name
DHCR24
Secondarily
Gene Name
KIAA0018
Sequence
MEPAVSLAVCALLFLLWVRLKGLEFVLIHQRWVFVCLFLLPLSLIFDIYYYVRAWVVFKLSSAPRLHEQRVRDIQKQVREWKEQGSKTFMCTGRPGWLTVSLRVGKYKKTHKNIMINLMDILEVDTKKQIVRVEPLVTMGQVTALLTSIGWTLPVLPELDDLTVGGLIMGTGIESSSHKYGLFQHICTAYELVLADGSFVRCTPSENSDLFYAVPWSCGTLGFLVAAEIRIIPAKKYVKLRFEPVRGLEAICAKFTHESQRQENHFVEGLLYSLDEAVIMTGVMTDEAEPSKLNSIGNYYKPWFFKHVENYLKTNREGLEYIPLRHYYHRHTRSIFWELQDIIPFGNNPIFRYLFGWMVPPKISLLKLTQGETLRKLYEQHHVVQDMLVPMKCLQQALHTFQNDIHVYPIWLCPFILPSQPGLVHPKGNEAELYIDIGAYGEPRVKHFEARSCMRQLEKFVRSVHGFQMLYADCYMNREEFWEMFDGSLYHKLREKLGCQDAFPEVYDKICKAARH
    Show/Hide
Organism
Homo sapiens, Human
Protein Classification
Enzyme
>
Oxidoreductase
Function
Catalyzes the reduction of the delta-24 double bond of sterol intermediates during cholesterol biosynthesis (PubMed:11519011, PubMed:21671375, PubMed:25637936, PubMed:22178193). In addition to its cholesterol-synthesizing activity, can protect cells from oxidative stress by reducing caspase 3 activity during apoptosis induced by oxidative stress (PubMed:11007892, PubMed:22010141). Also protects against amyloid-beta peptide-induced apoptosis (PubMed:11007892).
    Show/Hide
Uniprot ID
Primary ID:
Q15392

Secondarily ID:
B7Z817
D3DQ51
Q9HBA8
    Show/Hide
Ensembl ID
ENSG00000116133
HGNC ID
HGNC:2859
Subcellular Location
Endoplasmic reticulum membrane
Golgi apparatus membrane
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000018 , HL-60
Compound ID Compound Name Compound Formula
CP0494086
(3S,5S,9R,10S,13R,14R,17R)-17-[(2S)-1-hydroxypropan-2-yl]-10,13-dimethyl-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
   Show/Hide
C22H36O2
 1
1
IC50 = 0.1 nM
   TI
   LI
   LO
   TS
CP0252873
(4R)-4-[(1S,2R,5S,10S,11S,14R,15R)-5-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-14-yl]-N,N-dimethylpentanamide
   Show/Hide
C26H43NO2
 1
1
IC50 = 0.7 nM
   TI
   LI
   LO
   TS
CP0538753
(3S,8S,9S,10R,13S,14S,17R)-17-[(2S)-1-hydroxypropan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
   Show/Hide
C22H36O2
 1
1
IC50 = 2.5 nM
   TI
   LI
   LO
   TS
CP0538752
(3S,5S,9R,10S,13R,14R,17R)-10,13-dimethyl-17-[(E,2R)-4-(1-methylpyridin-1-ium-4-yl)but-3-en-2-yl]-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol;iodide
   Show/Hide
C29H42INO
 1
1
IC50 = 2.9 nM
   TI
   LI
   LO
   TS
CP0390331
[(3S,5S,9R,10S,13R,14R,17R)-17-[(2S)-1-hydroxypropan-2-yl]-10,13-dimethyl-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
   Show/Hide
C24H38O3
 1
1
IC50 = 3.3 nM
   TI
   LI
   LO
   TS
CP0520003
[(3S,5S,9R,10S,13R,14R,17R)-17-[(2S)-1-formyloxypropan-2-yl]-10,13-dimethyl-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
   Show/Hide
C25H38O4
 1
1
IC50 = 4.2 nM
   TI
   LI
   LO
   TS
CP0415322
[(2S)-2-[(3S,5S,9R,10S,13R,14R,17R)-3-acetyloxy-10,13-dimethyl-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]propyl] 2-(dimethylamino)acetate
   Show/Hide
C28H45NO4
 1
1
IC50 = 5.5 nM
   TI
   LI
   LO
   TS
CP0386783
[(2S)-2-[(3S,5S,9R,10S,13R,14R,17R)-3-acetyloxy-10,13-dimethyl-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]propyl] (E)-but-2-enoate
   Show/Hide
C28H42O4
 1
1
IC50 = 6.3 nM
   TI
   LI
   LO
   TS
CP0494085
[(3S,5S,9R,10S,13R,14R,17R)-17-[(2S)-1-aminopropan-2-yl]-10,13-dimethyl-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
   Show/Hide
C24H39NO2
 1
1
IC50 = 198 nM
   TI
   LI
   LO
   TS
CP0393648
[(2S)-2-[(3S,5S,9R,10S,13R,14R,17R)-3-acetyloxy-10,13-dimethyl-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]propyl] (E)-2-methylbut-2-enoate
   Show/Hide
C29H44O4
 1
1
IC50 = 203 nM
   TI
   LI
   LO
   TS
CP0520004
[(3S,5S,9R,10S,13R,14R,17R)-17-[(2S)-1-(methoxyamino)-1-oxopropan-2-yl]-10,13-dimethyl-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
   Show/Hide
C25H39NO4
 1
1
IC50 = 805 nM
   TI
   LI
   LO
   TS
CP0480900
[(3S,5S,9R,10S,13R,14R,17R)-10,13-dimethyl-17-[(2S)-1-(methylamino)-1-oxopropan-2-yl]-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
   Show/Hide
C25H39NO3
 1
1
IC50 = 823 nM
   TI
   LI
   LO
   TS
CP0562675
[(3S,5S,9R,10S,13R,14R,17R)-10,13-dimethyl-17-[(2S)-1-(propanoylamino)propan-2-yl]-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
   Show/Hide
C27H43NO3
 1
1
IC50 = 16900 nM
   TI
   LI
   LO
   TS
Clinical Information about the Protein
Target 1 ( Delta(24)-sterol reductase (DHCR24) )
Target Type Literature-reported Target
Disease 1 Target-related Disease  1
1 Obesity [ICD-11: 5B81]
Preclinical Drug(s) 1 Preclinical Drug  1
1 T-226293 Preclinical
Obesity